Literature DB >> 24001939

Role of miR-145 in cardiac myofibroblast differentiation.

Yao-Sheng Wang1, Shu-Hong Li1, Jian Guo1, Anton Mihic1, Jun Wu1, Lu Sun1, Kelly Davis1, Richard D Weisel1, Ren-Ke Li2.   

Abstract

Following a myocardial infarction (MI), fibroblasts differentiate to myofibroblasts, which possess some of the characteristics of smooth muscle cells (SMCs) and contribute to wound healing. Previous studies suggested that the miR-143/-145 cluster plays a critical role in SMC differentiation. Therefore, we determined whether miR-145 promoted differentiation of cardiac fibroblasts to myofibroblasts. Following coronary occlusion in mice, myocardial miR-145 expression was downregulated at 3 days but was restored at 7 days. In vitro studies showed that hypoxia also downregulated miR-145 in cardiac fibroblasts. The number of α-smooth muscle actin (α-SMA) positive cells in fibroblast cultures was employed to determine their transdifferentiation to cardiac myofibroblasts and was increased by 73.5% after transient transfection with miR-145. Ultrastructural analysis of α-SMA stress fibers revealed that ~95% of the α-SMA(+) cells treated with miR-145 organized their actin-filament bundles with a specific orientation compared to only 15% in the scrambled control group. This orientation of the SMA bundles and their integration with the filamentous actin fibers of the cytoskeleton permit infarct wound contraction. Structural and functional studies showed that miR-145 induced a myofibroblast phenotype, and miR-145 also potentiated the production of mature collagen by myofibroblasts. Repression of KLF5, a target of miR-145, was validated by a chimeric luciferase construct tagged with the full-length 3'-UTR of KLF5. A dramatic decrease in KLF5 and a corresponding increase in myocardin expression were observed after transfecting cultured fibroblasts with miR-145. Similar results were found in vivo: the transient decrease in miR-145 expression 3 days post-MI was associated with an increase in KLF5 and a decrease in myocardin. In addition, in vivo delivery of a miR-145 antagomir 1 day prior to and 2 and 6 days after MI decreased myofibroblast formation and increased scar size. The antagomir also reversed the suppressed expression of KLF5 protein in the scar region at day 7 after MI. In summary, we describe a novel association between miR-145 and fibroblast differentiation toward myofibroblasts. These observations provide a new approach to promote endogenous scar healing and contracture by stimulating the transdifferentiation of cardiac fibroblasts to myofibroblasts.
© 2013.

Entities:  

Keywords:  Cardiac myofibroblast; Infarct healing; KLF5; MI; Myocardin; SMC; SMHC; Smooth muscle cell; TGF-β; VSMC; alpha smooth muscle actin; miR-145; miRNA; microRNA; myocardial infarction; smooth muscle cell; smooth muscle myosin heavy chain; transforming growth factor beta; vascular smooth muscle cell; α-SMA

Mesh:

Substances:

Year:  2013        PMID: 24001939     DOI: 10.1016/j.yjmcc.2013.08.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  43 in total

1.  miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.

Authors:  Christiane Gras; Dominica Ratuszny; Catarina Hadamitzky; Haijiao Zhang; Rainer Blasczyk; Constança Figueiredo
Journal:  Mol Med       Date:  2015-04-09       Impact factor: 6.354

2.  Aspirin alleviates cardiac fibrosis in mice by inhibiting autophagy.

Authors:  Ping-Ping Liu; Hong-Hong Liu; Shu-Hong Sun; Xing-Xing Shi; Wan-Cheng Yang; Guo-Hai Su; Jing Zhao
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

3.  Expression of TGF-β1 and miRNA-145 in patients with diabetic foot ulcers.

Authors:  Fengmei Zhang; Yuguo Ren; Peng Liu; Yufeng Ren; Debao Wang
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

4.  Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1.

Authors:  Yun Hu; Feng Deng; Jinlin Song; Juhong Lin; Xue Li; Yuying Tang; Jie Zhou; Tian Tang; Leilei Zheng
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

5.  Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1.

Authors:  Yun Hu; Feng Deng; Jinlin Song; Juhong Lin; Xue Li; Yuying Tang; Jie Zhou; Tian Tang; Leilei Zheng
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

6.  Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.

Authors:  Jared M McLendon; Sachindra R Joshi; Jeff Sparks; Majed Matar; Jason G Fewell; Kohtaro Abe; Masahiko Oka; Ivan F McMurtry; William T Gerthoffer
Journal:  J Control Release       Date:  2015-05-13       Impact factor: 9.776

7.  Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.

Authors:  Shuo Fang; Chen Xu; Yuntong Zhang; Chunyu Xue; Chao Yang; Hongda Bi; Xijing Qian; Minjuan Wu; Kaihong Ji; Yunpeng Zhao; Yue Wang; Houqi Liu; Xin Xing
Journal:  Stem Cells Transl Med       Date:  2016-07-07       Impact factor: 6.940

8.  Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions.

Authors:  Liang Liang; Rivka C Stone; Olivera Stojadinovic; Horacio Ramirez; Irena Pastar; Anna G Maione; Avi Smith; Vanessa Yanez; Aristides Veves; Robert S Kirsner; Jonathan A Garlick; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

9.  miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1.

Authors:  Yong Wang; Liyan Jin
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

Review 10.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.